In vivo CAR T cell generation to treat cancer and autoimmune disease | Science

T cell therapies of chimerical antigen (CAR) have transformed the treatment of malignant tumors of B cells. However, their wider application is limited by complex manufacturing processes and the need for lymphodepléing chemotherapy, restricting the patient …